What the AAOS's new pain center signals for opioid-sparing recovery

On July 13, 2026, the American Academy of Orthopaedic Surgeons (AAOS) — the professional body for orthopedic surgery in the United States — launched a Pain Management Resource Center: an online hub to help surgeons and patients make more informed decisions about pain care before, during, and after surgery. The Academy called it the first step of a comprehensive pain initiative, built to help clinicians balance effective pain control with what it described as ongoing opioid concerns.

Why this matters more than it sounds

For years, opioid-sparing recovery was a case that individual surgeons and researchers made one at a time. A resource center from the specialty's own governing body is a different kind of signal: it means reducing opioid reliance after orthopedic surgery is moving from advocacy toward standard practice. It also follows earlier steps in the same direction, including the joint pain-alleviation toolkit the AAOS developed with the American Society of Anesthesiologists to help physicians manage post-operative pain with reduced opioid use.

The problem the field is responding to

The urgency is well documented. Among patients who had never taken opioids before surgery, an estimated 3.9% to 14% become new persistent users — still taking opioids months after they have healed — and those who do face substantially higher long-term mortality risk (Gong et al., BMC Surgery, 2024). The first 48 hours after surgery, when opioid use tends to compound, do a great deal to determine that outcome. Lowering early reliance is the lever the whole movement is reaching for.

Where non-drug, opioid-sparing tools fit

Opioid-sparing does not mean going without pain control. It means combining approaches — scheduled non-opioid medications, nerve blocks, movement, and non-drug adjuncts — so that opioids do less of the work. Targeted pulsed electromagnetic field (tPEMF) therapy is one such non-drug adjunct. SofPulse tPEMF is FDA-cleared as an adjunctive treatment for post-operative pain and edema in soft tissue, and in published double-blind trials it reduced post-operative pain and narcotic use. It is designed to work alongside a surgeon's plan, not instead of it — the same multimodal philosophy the new resource center describes.

One honest clarification

To be clear about what this is and is not: the AAOS Pain Management Resource Center does not endorse specific products, and Heal Without and SofPulse are not affiliated with the Academy or its initiative. Nothing here should be read as an AAOS recommendation of any device. The point is narrower, and more useful — the direction the field is moving, toward planned, multimodal, opioid-sparing recovery, is the same direction this device was built to serve. When the leading orthopedic body and the published evidence point the same way, patients benefit from knowing it.

If you have surgery coming up, the practical takeaway is the one the AAOS is now making easier to act on: ask your surgeon about a multimodal, opioid-sparing plan, and ask which non-drug adjuncts fit your case. This is educational, not medical advice — your surgeon's guidance comes first. But those questions are more welcome today than they have ever been.